Title : Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.

Pub. Date : 2002 Jun 1

PMID : 12010810






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Several established or novel anti-multiple myeloma (anti-MM) agents, such as dexamethasone, thalidomide, and proteasome inhibitors (PS-341), inhibit NF-kappaB activity as part of their diverse actions. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens